General Session II | Improving Medication Access and Affordability: The IRA and Medicare

Wednesday, May 15, 2024

9:30am – 10:45am ET

Location: Key 5-8

Moderator(s)

Christopher Powers, PharmD

Director of Medicare Stars Data and Analytics
Cigna Insurance Company

Speaker(s)

Alison Falb, JD

Health Policy Director
Applied Policy

Panelist(s)

Alexandra Broadus, PharmD

Senior Director, Clinical Pharmacy Strategy
Walgreens
Margaret Davis, MHS

Team Leader, Federal Policy
Pfizer
Mariah Forster Olson, MBA

Patient

The Inflation Reduction Act’s (IRA) yearly out-of-pocket cap on prescription drug costs and Medicare Prescription Payment Plan take effect in 2025 to improve patient access to affordable medications. An expert presentation on these IRA provisions and a panel discussion will offer insights into the implications for various health care sectors and feature the patient perspective on medication access.